| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Altman Peter is a President And CEO at BCDA. Recent filings cover 128 purchases and 1 sale. Those positions are worth an estimated $366K at current prices.
Our model assigns Altman Peter a below-average insider score of 46/100, based on 57 past trades. Over a 12-month horizon, 17.8% of those trades were profitable, with an average 12-month return of -33.2%.
Altman Peter's largest disclosed position is in BCDA as President And CEO, worth about $366K. Net of sales, the recent Form 4 record there shows accumulation of 400,324 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 20, 2018 | BCDA Biocardia, Inc. | President And CEO | Buy | 1,100 | $1.74 | $1,914.40 | - | |
| Sep 19, 2018 | BCDA Biocardia, Inc. | President And CEO | Buy | 700 | $1.65 | $1,154.00 | - | |
| Sep 18, 2018 | BCDA Biocardia, Inc. | President And CEO | Buy | 700 | $1.59 | $1,110.00 | - | |
| Sep 12, 2018 | BCDA Biocardia, Inc. | President And CEO | Buy | 1,600 | $1.37 | $2,184.00 | +0.1% | |
| Sep 5, 2018 | BCDA Biocardia, Inc. | President And CEO | Buy | 5,000 | $1.33 | $6,650.00 | +0.7% | |
| Aug 27, 2018 | BCDA Biocardia, Inc. | President And CEO | Buy | 1,500 | $1.46 | $2,190.00 | +0.2% | |
| Jun 11, 2018 | BCDA Biocardia, Inc. | President And CEO | Buy | 3,000 | $1.45 | $4,350.00 | +0.4% | |
| Apr 18, 2018 | BCDA Biocardia, Inc. | President And CEO | Buy | 1,000 | $1.45 | $1,450.00 | +0.1% | |
| Mar 20, 2018 | BCDA Biocardia, Inc. | President And CEO | Buy | 5,000 | $2.03 | $10,150.00 | +0.7% |